Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
Sign Up to like & getrecommendations! Published in 2022 at "Oncoimmunology"
DOI: 10.1080/2162402x.2022.2069214
Abstract: ABSTRACT The extracellular matrix component biglycan (BGN) plays an essential role in various physiological and pathophysiological processes. A deficient BGN expression associated with reduced immunogenicity was found in HER-2/neu-overexpressing cells. To determine whether BGN is… read more here.
Keywords: bgn; immunogenicity; ras transformed; expression ... See more keywords